- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about BNTX
Recent news which mentions BNTX
Novavax Stock Is a Bet on Interest From Unvaccinated People
March 30, 2022
From InvestorPlace
From Benzinga
Why Moderna and BioNTech Were Winners Today
March 29, 2022
From Motley Fool
FDA Authorizes Fourth Dose Of Moderna, Pfizer/BioNTech COVID-19 Vaccines For Older People
March 29, 2022
From Benzinga
From Benzinga
From MarketWatch
From Benzinga
Overview Of Value Stocks In The Healthcare Sector
March 28, 2022
From Benzinga
Are These 2 Rivals Beating Pfizer and Moderna?
March 28, 2022
From Motley Fool
From Benzinga
From Motley Fool
These 3 Stocks Aren't Large Caps Yet, but They Each Could Make $1 Billion in Sales in 2022
March 25, 2022
From Motley Fool
The U.S. is talking about a second round of COVID-19 booster shots, and it’s going to be even more complicated than last year
March 25, 2022
From MarketWatch
Why Moderna, BioNTech, and Novavax Stocks Are Tumbling Today
March 25, 2022
From Motley Fool
2 Green Flags for Pfizer's Future
March 25, 2022
From Motley Fool
From MarketWatch
Why Most Kids Did Not Suffer Badly Due To COVID-19 Infection? Scientists Look To Solve Mystery: CNBC
March 24, 2022
From Benzinga
Is It Time to Buy COVID-19 Vaccine Stocks Again?
March 24, 2022
From Motley Fool
Biden Administration Contemplating Second COVID-19 Booster Shot Recommendation Within Weeks: Politico
March 23, 2022
From Benzinga
From Benzinga
From Motley Fool
From Benzinga
Moderna’s stock, down 60% since the summer’s delta wave, is rising again as COVID-19 cases increase
March 21, 2022
From MarketWatch
5 Value Stocks To Watch In The Healthcare Sector
March 21, 2022
From Benzinga
Health Experts Forecast Increase In COVID-19 Cases In US Amid New Omicron Subvariant: CNBC
March 21, 2022
From Benzinga
Maker Of Pfizer's COVID-19 Vaccine mRNA-Delivery Tech Sues Arbutus Biopharma: Reuters
March 18, 2022
From Benzinga
Why BioNTech Stock Is Jumping Today
March 18, 2022
From Motley Fool
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.